https://doi.org/10.4081/cc.2024.15761

ID-Migraine test for pediatric population: preliminary results from the Italian validation

Vol. 34 No. 1 (2024)
Submitted: 20 March 2024
Accepted: 14 April 2024
Published: 7 May 2024
Migraine, pediatric, Italian validation, ID-Migraine
Abstract Views: 1679
PDF: 333
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Ilaria Frattale
ilariafrattale@libero.it
Child Neurology and Psychiatry Unit, Department of Wellbeing of Mental and Neurological, Dental and Sensory Organ Health, Tor Vergata Foundation Hospital, Rome, Italy.
Laura Papetti
Developmental Neurology, IRCCS Bambino Gesù Children Hospital, Rome, Italy.
Fabiana Ursitti
Developmental Neurology, IRCCS Bambino Gesù Children Hospital, Rome, Italy.
Giorgia Sforza
Developmental Neurology, IRCCS Bambino Gesù Children Hospital, Rome, Italy.
Gabriele Monte
Developmental Neurology, IRCCS Bambino Gesù Children Hospital, Rome, Italy.
Luigi Mazzone
Child Neurology and Psychiatry Unit, Department of Wellbeing of Mental and Neurological, Dental and Sensory Organ Health, Tor Vergata Foundation Hospital, Rome, Italy.
Massimiliano Valeriani
Center for Sensory-Motor Interaction, Aalborg University, Denmark; Developmental Neurology, IRCCS Bambino Gesù Children Hospital, Rome; System Medicine Department, Tor Vergata University of Rome, Italy.

Background: Migraine is a frequent neurological condition with a high impact on quality life. The diagnosis is clinical in accordance with the International Classification of Headache Disorders version 3 criteria. Early diagnosis is important to initiate timely treatment. A screening tool for adulthood is already available (ID-Migraine), while there is currently no questionnaire that allows for diagnosis in children and adolescents. The aim of the present study is to demonstrate the validity of ID-Migraine to diagnose migraine in pediatric population.
Methods: A total of 94 pediatric patients were enrolled and administered ID-Migraine. The mean age was 11.6 years. The study group included patients with a diagnosis of migraine (63%) and primary stabbing headache (37%).
Results and conclusions: Specificity and positive predictive values were >80% (92% and 93% respectively); sensitivity and negative predictive values tended towards reliability (71% and 66% respectively), making the ID-Migraine a reliable tool in diagnosing migraine in the pediatric population.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Abu‐Arafeh I, Razak S, Sivaraman B, Graham C. Prevalence of headache and migraine in children and adolescents: a systematic review of population‐based studies. Dev Med Child Neurol 2010;52:1088-97. DOI: https://doi.org/10.1111/j.1469-8749.2010.03793.x
Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1211-59. DOI: https://doi.org/10.1016/S0140-6736(17)32154-2
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38:1-211. DOI: https://doi.org/10.1177/0333102417738202
Torriero R, Capuano A, Mariani R, Frusciante R, Tarantino S, Papetti L, et al. Diagnosis of primary headache in children younger than 6 years: a clinical challenge. Cephalalgia 2017;37:947-54. DOI: https://doi.org/10.1177/0333102416660533
Özge A, Faedda N, Abu-Arafeh I, Gelfand AA, Goadsby PJ, Cuvellier JC, et al. Experts’ opinion about the primary headache diagnostic criteria of the ICHD-3rd edition beta in children and adolescents. J Headache Pain 2017;18:109. DOI: https://doi.org/10.1186/s10194-017-0818-y
Lipton RB, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J, et al. A self-administered screener for migraine in primary care: the ID MigraineTM validation study. Neurology 2003;61:375-82. DOI: https://doi.org/10.1212/01.WNL.0000078940.53438.83
Brighina F, Salemi G, Fierro B, Gasparro A, Balletta A, Aloisio A, et al. A validation study of an Italian version of the ID Migraine. Headache 2007;47:905-8. DOI: https://doi.org/10.1111/j.1526-4610.2006.00628.x
Zarifoğlu M, Karli N, Taşkapilioğlu Ö. Can ID Migraine TM be used as a screening test for adolescent migraine? Cephalalgia 2008;28:65-71. DOI: https://doi.org/10.1111/j.1468-2982.2007.01470.x
Jin Z, Shi L, Wang YJ, Yang LG, Shi YH, Shen LW, et al. Prevalence of headache among children and adolescents in Shanghai, China. J Clin Neurosci 2013;20:117-21. DOI: https://doi.org/10.1016/j.jocn.2012.02.020
Monte G, Papetti L, Ursitti F, Sforza G, Tarantino S, Checchi Proietti M, et al. Childhood primary stabbing headache: a double center study. Cephalalgia 2024;44:03331024231225974. DOI: https://doi.org/10.1177/03331024231225974

How to Cite

1.
Frattale I, Papetti L, Ursitti F, Sforza G, Monte G, Mazzone L, et al. ID-Migraine test for pediatric population: preliminary results from the Italian validation. Confinia Cephalal [Internet]. 2024 May 7 [cited 2024 Nov. 1];34(1). Available from: https://www.confiniacephalalgica.com/site/article/view/15761
Copyright (c) 2024 the Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.